CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 841966887
- Phone
- (888) 378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 62 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-19 | COATS LONNEL Director | Grant or award | +12,400 | 12,400 | ||
| 2026-10-19 | COATS LONNEL Director | Grant or award · Stock Option | +16,600 | 16,600 | ||
| 2026-10-19 | Peterson Kristine Director | Grant or award | +12,400 | 12,400 | ||
| 2026-10-19 | Peterson Kristine Director | Grant or award · Stock Option | +16,600 | 16,600 | ||
| 2026-09-30 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −75,000 | $25.46 | $1.9M | 528,621 |
| 2026-09-22 | Slingsby Brian Taylor Director | Sale | −104,320 | $28.81 | $3.0M | 7,805,718 |
| 2026-09-21 | Warren Eric Chief Commercial Officer | Option exercise 10b5-1 | +7,438 | $13.24 | $98K | 45,838 |
| 2026-09-21 | Warren Eric Chief Commercial Officer | Sale 10b5-1 | −7,438 | $28.12 | $209K | 38,400 |
| 2026-09-21 | Warren Eric Chief Commercial Officer | Option exercise · Stock Option 10b5-1 | −7,438 | 230,563 | ||
| 2026-09-15 | Karydas Daphne Director | Option exercise 10b5-1 | +3,000 | $12.02 | $36K | 9,200 |
| 2026-09-15 | Karydas Daphne Director | Sale 10b5-1 | −3,000 | $28.58 | $86K | 6,200 |
| 2026-09-15 | Karydas Daphne Director | Option exercise · Stock Option 10b5-1 | −3,000 | 35,000 | ||
| 2026-08-21 | Warren Eric Chief Commercial Officer | Option exercise 10b5-1 | +7,437 | $13.24 | $98K | 45,837 |
| 2026-08-21 | Warren Eric Chief Commercial Officer | Sale 10b5-1 | −7,437 | $25.98 | $193K | 38,400 |
| 2026-08-21 | Warren Eric Chief Commercial Officer | Option exercise · Stock Option 10b5-1 | −7,437 | 238,001 | ||
| 2026-08-10 | Ferguson James J. III Chief Medical Officer | Grant or award | +102,400 | 102,400 | ||
| 2026-08-10 | Ferguson James J. III Chief Medical Officer | Grant or award · Stock Option | +135,000 | 135,000 | ||
| 2026-08-10 | Rodman David Malcom Chief Medical Officer | Option exercise 10b5-1 | +2,170 | $16.00 | $35K | 53,554 |
| 2026-08-10 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −2,170 | $27.09 | $59K | 51,384 |
| 2026-08-10 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −2,170 | 13,024 |
Page 1 of 17 · 321 trades